Press Releases April 15, 2026 08:00 PM

Abacus Global Management to Announce First Quarter 2026 Financial Results on Thursday, May 7, 2026

Abacus Global Management to Release Q1 2026 Financial Results on May 7, 2026

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
ABX

Abacus Global Management, a NYSE-listed alternative asset management firm, announced that it will release its first quarter 2026 financial results after market close on May 7, 2026, followed by a conference call to discuss the results.

Abacus Global Management to Announce First Quarter 2026 Financial Results on Thursday, May 7, 2026
ABX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Abacus Global Management specializes in alternative asset management and wealth solutions leveraging data analytics.
  • The company will report Q1 2026 financial results on May 7, 2026, with a subsequent investor conference call.
  • Abacus focuses on longevity-based assets and personalized financial planning for individuals and institutions.

ORLANDO, Fla., April 16, 2026 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. ("Abacus" or the "Company") (NYSE: ABX), a leader in the alternative asset management industry, today announced it will release its first quarter 2026 financial results after the market closes on Thursday, May 7, 2026.

Abacus will hold a conference call to discuss the financial results at 5 pm Eastern Time on May 7, 2026. A live webcast of the conference call will be available on Abacus’ investor relations website at ir.abacusgm.com. The dial-in number for the conference call is (844) 512-2921 (toll-free) or (412) 317-6671 (International) and participants must enter Conference ID “ABACUS” when joining. Please dial the number 10 minutes prior to the scheduled start time.

A webcast replay of the call will be available here for one year following the call.

About Abacus

Abacus Global Management (NYSE: ABX) is a leading financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. With a focus on longevity-based assets and personalized financial planning, Abacus leverages proprietary data analytics and decades of industry expertise to deliver innovative solutions that optimize financial outcomes for individuals and institutions worldwide.

For more information, please visit www.abacusgm.com

Contact:

Investor Relations

Robert F. Phillips – SVP Investor Relations and Corporate Affairs

[email protected]

(321) 290-1198

David Jackson – Managing Director of Investor Relations

[email protected]

(321) 299-0716

Abacus Public Relations

[email protected]


Risks

  • Potential uncertainties related to the financial performance in Q1 2026 that will be disclosed in the upcoming earnings report.
  • Market reaction could be influenced by the company’s reported results and its outlook on alternative asset markets.
  • Economic factors affecting alternative asset management and wealth solutions sectors could impact future company performance.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026